CN Patent

CN115160319B — 含1,3-苯并二氧戊环结构的化合物及其制备方法与用途

Assigned to XI'AN XINTONG PHARMACEUTICAL RESEARCH CO LTD · Expires 2023-12-26 · 2y expired

What this patent protects

本发明公开了含1,3‑苯并二氧戊环结构的化合物及其制备方法与用途。本发明公开了一种通式(I)所示的1,3‑苯并二氧戊环衍生物，药理实验结果显示，本发明的化合物(I)可以对BTK和JAK3激酶产生良好的抑制作用，可用于制备治疗BTK、JAK3通路过度活化所致的类风湿性关节炎的药物；本发明还公开了所述1,3‑苯并二氧戊环衍生物的制备方法。

USPTO Abstract

本发明公开了含1,3‑苯并二氧戊环结构的化合物及其制备方法与用途。本发明公开了一种通式(I)所示的1,3‑苯并二氧戊环衍生物，药理实验结果显示，本发明的化合物(I)可以对BTK和JAK3激酶产生良好的抑制作用，可用于制备治疗BTK、JAK3通路过度活化所致的类风湿性关节炎的药物；本发明还公开了所述1,3‑苯并二氧戊环衍生物的制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN115160319B
Jurisdiction
CN
Classification
—
Expires
2023-12-26
Drug substance claim
No
Drug product claim
No
Assignee
XI'AN XINTONG PHARMACEUTICAL RESEARCH CO LTD
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.